Basic information Safety Supplier Related

6-BROMOSACCHARINE

Basic information Safety Supplier Related

6-BROMOSACCHARINE Basic information

Product Name:
6-BROMOSACCHARINE
Synonyms:
  • RARECHEM AM UH V180
  • 6-BROMOSACCHARINE
  • 6-Bromobenzo[d]isothiazol-3(2H)-one 1,1-dioxide
  • 6-bromosaccharin
  • 6-bromo-1,2-benzisothiazol-3(2H)-one 1,1-dioxide
  • 6-Bromo-1,2-benzisothiazol-3-one 1,1-dioxide
  • 1,2-Benzisothiazol-3(2H)-one, 6-bromo-, 1,1-dioxide
  • 6-bromo-2H-1???,2-benzothiazole-1,1,3-trione
CAS:
62473-92-1
MF:
C7H4BrNO3S
MW:
262.08
Mol File:
62473-92-1.mol
More
Less

6-BROMOSACCHARINE Chemical Properties

Density 
1.958±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
pka
1.15±0.30(Predicted)
Appearance
White to light yellow Solid
InChI
InChI=1S/C7H4BrNO3S/c8-4-1-2-5-6(3-4)13(11,12)9-7(5)10/h1-3H,(H,9,10)
InChIKey
CNDPIUXFHSMKMG-UHFFFAOYSA-N
SMILES
S1(=O)(=O)C2=C(C=CC(Br)=C2)C(=O)N1
More
Less

6-BROMOSACCHARINE Usage And Synthesis

Synthesis

135484-83-2

62473-92-1

Methyl 2-amino-4-bromobenzoate (4.5 g, 20 mmol) was stirred in 20% hydrochloric acid (30 mL) until completely dissolved. The solution was cooled to 0 °C, the reaction temperature was controlled not to exceed 5 °C, and a solution of sodium nitrite (1.4 g, 0.020 mol) in water (20 mL) was added dropwise. The mixture was stirred at 0°C for 45 min. Meanwhile, sulfur dioxide was passed into a mixture of acetic acid (50 mL) and water (5 mL) to saturation at 0 °C, followed by the addition of copper (I) chloride (2.0 g, 0.020 mol). The mixture was cooled to 0 °C and the diazonium salt solution was added dropwise over 30 min with vigorous stirring. The reaction mixture was stirred at 0 °C for 1 h. After stirring, the mixture was slowly warmed to room temperature and stirring was continued for 2 h. The mixture was then cooled to room temperature. The mixture was poured into ice water (250 mL) and extracted with EtOAc (3 x 50 mL). The organic phase was washed with saturated NaHCO3 solution and dried over anhydrous Na2SO4. The solvent was concentrated under reduced pressure to give an oily residue, which was dissolved in tetrahydrofuran (40 mL) and cooled to 0 °C. Cold (0°C) 28% ammonium hydroxide solution (40 mL) was added in batches and the reaction temperature was controlled to be below 10°C. The mixture was warmed to room temperature and stirred for 1 hour. The solvent was removed under reduced pressure and the residue was dissolved in saturated aqueous sodium bicarbonate solution (40 mL) and washed with ether (50 mL). The aqueous layer was acidified to pH 1 with concentrated hydrochloric acid, the precipitate was collected by filtration and dried under vacuum to give 6-bromo-1,1-dioxo-1,2-dihydro-1λ6-benzo[d]isothiazol-3-one (500 mg, 10% yield).1H NMR (400 MHz, DMSO) δ 8.44 (d, J=1.5, 1H), 8.04 (dd, J=8.1,1.5, 1H), 7.81 (d, J=8.1,1.5, 1H), 7.81 (d, J=8.1,1.5, 1.1.5, 1.1.5, 1H). 1H), 7.81 (d, J=8.0,1H).

References

[1] Bioorganic and Medicinal Chemistry, 2005, vol. 13, # 4, p. 949 - 961
[2] Patent: US2008/9524, 2008, A1. Location in patent: Page/Page column 410
[3] Patent: US2015/231142, 2015, A1. Location in patent: Paragraph 1267

6-BROMOSACCHARINESupplier

Zhuzhou focus pharmaceutical technology co., LTD Gold
Tel
+86-13776644403
Email
robert@focuspharma.cc
Shureli Biopharma Co.,Ltd Gold
Tel
0871-68355600 18787766125
Email
756338076@qq.com
Bide Pharmatech Ltd.
Tel
400-164-7117 13681763483
Email
product02@bidepharm.com
Cool Pharm, Ltd
Tel
021-60455363 18019463053
Email
sales@coolpharm.com
Shanghai SuperLan Chemcial Technique Centre
Tel
0-2022843681 15618226720
Email
chaolaichem@foxmail.com